IL36983A - N-(p-beta-(8-quinolinylcarboxamidoethyl)-benzenesulphonyl)-ureas and process for their manufacture - Google Patents

N-(p-beta-(8-quinolinylcarboxamidoethyl)-benzenesulphonyl)-ureas and process for their manufacture

Info

Publication number
IL36983A
IL36983A IL36983A IL3698371A IL36983A IL 36983 A IL36983 A IL 36983A IL 36983 A IL36983 A IL 36983A IL 3698371 A IL3698371 A IL 3698371A IL 36983 A IL36983 A IL 36983A
Authority
IL
Israel
Prior art keywords
group
benzenesulphonyl
substituted
urea
carbon atoms
Prior art date
Application number
IL36983A
Other versions
IL36983A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19702027950 external-priority patent/DE2027950A1/en
Priority claimed from DE19712120266 external-priority patent/DE2120266A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL36983A0 publication Critical patent/IL36983A0/en
Publication of IL36983A publication Critical patent/IL36983A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Claims (2)

1. HOE 70/F Q96K we claim is : Benzenesulphonyl urea derivatives of the formula in which X represents a hydrogen, chlorine or "bromine atom, a methoxy or methyl group, Y represents -CH(CH5)-CH2-, -CH2-CH(CH5)- or preferably R represents a) an alkyl group of 3 to 6 carbon atoms, b) a cycloalkyl group of 5 to 8 carbon atoms, which may be substituted by 1 or 2 alkyl groups of up to 3 carbon atoms in total or by a chlorine atom, c) a cycloalkenyl group of 5 to 8 carbon, atoms, which may be substituted by 1 or 2 alkyl groups of 3 carbon atoms in total, d) a bicycloalkyl or bicycloalkenyl group of 7 or 8 carbon atoms, e) a nortricyclyl group, fjg) an alkylene-imino radical of 3 to 7 carbon atoms in the ring, which may be unoaturatod or substituted by 1 or 2 methyl groups or a lower alkyl group or a methoxy group, 36983/2 . ·» Z represents a hydrogen atom or a methylene or dlmethylene group, which forms together with Y a 5- or 6- membe ed ring* and the salts thereof.
2. ) N^^*6*ohloro»quinolino-8*oarboxamido-ethyl)-benzene-sulphonyl/- *•cyclohexyl*«rea. sulphonyl^-N'·(4»methyl cyclohexyl)-urea. 8) -^5-(p»6^ohloro-quinolino-8-carboxamido-ethyl)-benzene- sulphonyl/*!*1*(3*methyl^pentamethylene)«·semicarbazide. HOE 70/F Q96K 9) 4-/ -( B-6-chloro-quinolino-8-carboxamido-ethyl)-benzene- sulphonyl/-l,l-pentamethylene-semicarbazide. 10) 4- 4-( B-6-chloro-quinolino-8-carboxamido-ethyl)-benzene- sulphony1/-1 ,1-hexamethylene-semicarbazide . 11) 4- -( B-6-chloro-quinolino-8-carboxamido-ethyl)-benzene- 8ulphonyl7~l , 1-( 3-ethy1-pentamethylene )-semicarbazide . 12) 4-/4-(β-6-bromo-quinolino-8-carboxamido-ethyl)-benzene- sulphonyl7~l , i-hexamethylene-semicarbazide . 13). A process for the manufacture of benzenesulphonyl-ureas as claimed in claim 1, which comprises introducing, optionall stepwise, into a compound containing the grouping I of the formula in which n is 0,1 or 2. a radical II of the formula and a radical III of the formula - CO - NH - R III radicals I and III being linlced by means of a NH- group contained either in radical I or in radical III, . ": optionally oxidizing the reaction products subsequently and treating them, where required, with alkaline agents or physiologically tolerable inorganic or organic acids, for salt formation. HOE 70/P 096K 14) A process for the manufacture of benzenesulphony1-ureas of the formula in which X represents a hydrogen, chlorine or "bromine atom, a methoxy or methyl group, Ϊ represents -CH(0H5)-CH2-f- -CH2-CH(CH5)- or preferably -CH2-CH2~ , R represents a) an alkyl group, of 3 to 6 carbon atoms, b) a cycloalkyl group of 5 to 8 carbon atoms, which may be substituted by 1 or 2 alkyl groups of up to 3 carbon atoms in total or by a chlorine atom, c) a cycloalkenyl group of 5 to 8 carbon atoms, which may be substituted by 1 or 2 alkyl groups of 3 carbon atoms in total, d) a bicycloalkyl or bicycloalkenyl group of 7 or 8 carbon atoms, e) a nortricyclyl group, . f) a opiro 2,fl7"heptyl grou ?. Mffaytfie cr et 'meM /en represents a hydrogen atom or a h^4^-ea- ¾-G?i^ r€-al—oLJl—c - Or oa-rbon a-e-m-e-, which forms together with Y a 5- or 6-raembered ring, and the salts thereof, as claimed in Claim 13, which comprises a) reacting a benzenesulphonyl-isocyanate , benzenesul- phonyl-carbamic acid ester, benzenesulphon 1-thiolcar- bamic acid ester, benzenesulphonyl-urea, benzenesulphonyl- HOE 70/F Q96K with an amine R-NHg or Bait thereof, or reacting a sul-phonamide of the formula or a salt thereof with a R^-substituted isocyanate, car-baDiic acid ester, thiolcarbamic acid ester, carbamic acid halide or urea; saponifying or hydrolysing a correspondingly substituted benzenesulphonyl-isourea ether, benzenesulphonyl-isourea ester, benzenesulphonyl- isothiourea ether, benzenesul" phonyl-isothiourea ether , benzenesulphonyl-parabanic acid or benzenesulphonyl- haloformic acid amidine or a compound of the formula wherein U stands for cocygon^lower-a-3rrey-i , sul hur-1pwe-κ- al½yl or halogen (preferably chlorine) ; replacing in a correspondingly substituted benzenesul- phony1-thiourea or thioamido-alk l-benzenesulphonyl- urea or -thiourea, the sulphur atom or sulphur atoms of the thio-urea and/or thio-amido group by an oxygen atom or oxygen atoms , or adding' ater to a correspondingly substituted carbodiimide ; Oxidizin a corres ondin l substituted benzenesul hin l V e) introducing the group "by acylation optionally in one or more steps, into a benzenesulphony1-urea of ■ he - formula reacting a correspondingly substituted benzenesulphonyl- halide v/ith a R-substituted urea or an alkali metal salt thereof; or reacting a correspondingly substituted benzene sulphinic acid halide or, in the presence of an acid condensation agent, even a correspondingly substituted sulphinic acid or alkali metal salt thereof with N-R-N' -hydroxy-urea ; and, where required, treating the reaction product so obtained with an alkaline agent or with a physiologically acceptable inorganic or organic acid, for salt formation. A process for the manufacture of benzenesulphonyl-ureas in which X represents a hydrogen, chlorine or bromine atom, or a methyl or methoxy group, Y represents Z represents -carbon a ome, which forms together with Ϊ a 5- or 6- an alkylene-imino radical of 3 to 7 carbon atoms in the ring, which may be unsaturated or substituted by 1 or 2. methyl groups or a lower alkyl group or a methoxy group, a pentamethylene-imino radical which is substituted by an endoalkylene group of 1 to 3 carbon atoms, a hexamethylene-imino radical which is substituted by an endoethylene group in β-ε-positbn, or a tetrahydro-isoindoline, a 4 , 7~endoalkylene-hexa-hydro- or -tetrahydro-isoindoline radical, the endoalkylene group containing 1 or 2 carbon atoms and the double bond of the tetrahydro compound being in 5,6- position, and the salts thereof, as claimed in claim 13, which comprises reacting a benzenesulphonamide of the formula or a salt thereof, with an imino-carbamic acid ester, imino-thiocarbamic acid ester or imino-urea containing as the imino group the group R-, reacting an amine of the formula RNH2 or a salt thereof with a benzenesulphonyl-isocyanate , benzensul-phonyl-carbamic acid ester, benzenesulphonyl-thiol-carbamic acid ester, benzenesulphonyl-carbamic acid halide or benzene-sulphonyl-urea, substituted in3-position by the group Z and in 4-position by the group reacting a benzenesulphochloride of the formula with a R-substituted urea, hydrolizing a benzenesulphonyl-isourea ether, ben-zenesulphonyl-isothiourea ether or benzene-sul hon 1 imino-parabahic acid derivative substituted by R, Z and replacing in a benzenesulphonylr-thiourea of the formula the sulphur atom by an oxygen atom, or introducing the radical 36933/2 v optionally step by step, into a benzene sulphonyl- urea of the formula Π 2Ν " Y 5 C) 'J- ~ NH " C0 ~ HH ~ U and, where required, treating the reaction product for salt formation with an alkaline agent or a ph siologically acceptable inorganic or organic acid. 16) Λ process for the manufacture of pharmaceutical preparations for oral administration and lowering the blood sugar level in the treatment of diabetes mellitus, which comprises bringing a benzenesulphonyl-urea of the formula specified in claim 1 or a salt thereof, optionally in admixture or conjunction with a suitable carrier, into a pharmaceutically suitable dosage unit form. 17) Pharmaceutical preparations for oral administration and lov/ering the blood sugar level in the treatment of diabetes mellitus, which comprise a content of a benzenesulphonyl-urea defined in claim 1 or a salt thereof.
IL36983A 1970-06-06 1971-06-04 N-(p-beta-(8-quinolinylcarboxamidoethyl)-benzenesulphonyl)-ureas and process for their manufacture IL36983A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19702027950 DE2027950A1 (en) 1970-06-06 1970-06-06 Benzenesulfonylureas and process for their preparation
DE19712120266 DE2120266A1 (en) 1971-04-26 1971-04-26 Benzenesulfonyl semicarbazides and processes for their preparation

Publications (2)

Publication Number Publication Date
IL36983A0 IL36983A0 (en) 1971-08-25
IL36983A true IL36983A (en) 1976-03-31

Family

ID=25759238

Family Applications (1)

Application Number Title Priority Date Filing Date
IL36983A IL36983A (en) 1970-06-06 1971-06-04 N-(p-beta-(8-quinolinylcarboxamidoethyl)-benzenesulphonyl)-ureas and process for their manufacture

Country Status (15)

Country Link
BE (1) BE768135A (en)
BG (1) BG19796A3 (en)
CA (1) CA986114A (en)
CH (12) CH576972A5 (en)
DK (1) DK138793C (en)
ES (3) ES391792A1 (en)
FI (1) FI50792C (en)
FR (1) FR2100731A1 (en)
HU (1) HU166708B (en)
IE (1) IE35332B1 (en)
IL (1) IL36983A (en)
IT (1) IT1037032B (en)
NL (1) NL7107502A (en)
RO (1) RO58731A (en)
SE (1) SE361038B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1294957B (en) * 1966-07-02 1969-05-14 Boehringer & Soehne Gmbh Process for the preparation of hydrindene sulphonylureas and sulphonyl semicarbazides

Also Published As

Publication number Publication date
RO58731A (en) 1975-12-15
DK138793B (en) 1978-10-30
DK138793C (en) 1979-03-26
CH576971A5 (en) 1976-06-30
CH580593A5 (en) 1976-10-15
CH577479A5 (en) 1976-07-15
ES418120A1 (en) 1976-09-01
CH576972A5 (en) 1976-06-30
CH576973A5 (en) 1976-06-30
ES444834A1 (en) 1977-05-01
CA986114A (en) 1976-03-23
SE361038B (en) 1973-10-15
FI50792C (en) 1976-07-12
IL36983A0 (en) 1971-08-25
CH568291A5 (en) 1975-10-31
BG19796A3 (en) 1975-10-10
CH577974A5 (en) 1976-07-30
CH586203A5 (en) 1977-03-31
CH577478A5 (en) 1976-07-15
IE35332L (en) 1971-12-06
CH586219A5 (en) 1977-03-31
BE768135A (en) 1971-12-06
CH576965A5 (en) 1976-06-30
ES391792A1 (en) 1974-08-01
NL7107502A (en) 1971-12-08
CH577498A5 (en) 1976-07-15
HU166708B (en) 1975-05-28
IE35332B1 (en) 1976-01-21
FR2100731A1 (en) 1972-03-24
IT1037032B (en) 1979-11-10
FI50792B (en) 1976-03-31
FR2100731B1 (en) 1974-09-06

Similar Documents

Publication Publication Date Title
US4379785A (en) Heterocyclic substituted sulfonyl ureas, and their use
US20020151586A1 (en) Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
US4315940A (en) Antidiabetic 1-piperidine-sulfonylureas
US3998828A (en) 4-[2-(1,3-Dialkyl-1,2,3,4-tetra-hydropyrimidine-2,4-dione-5-carboxamido)ethyl]-1-piperidine sulfonamide
DE1518879A1 (en) Benzenesulfonylureas and process for their preparation
DE1940131A1 (en) Thiophenesulfonylureas and process for their preparation
US3829434A (en) Piperidinesulfonylurea derivatives
DE2621958A1 (en) BENZENE SULFONYL URUBE AND METHOD FOR MANUFACTURING IT
IL36983A (en) N-(p-beta-(8-quinolinylcarboxamidoethyl)-benzenesulphonyl)-ureas and process for their manufacture
EP0073507B1 (en) Sulfonyl ureas, process for their preparation, pharmaceutical compositions containing them and their use
EP0089597A2 (en) Sulphonyl ureas, process for their preparation, pharmaceutical compositions containing them and their use
US3987172A (en) Piperidinesulfonylurea derivatives
US3961065A (en) Benzenesulfonylurea derivatives
US3914426A (en) Piperidinesulfonylurea derivatives for lowering blood sugar levels
DE1568606C3 (en) Benzenesulfonylureas, processes for their preparation and pharmaceutical preparations containing them
US3944524A (en) 4-Substituted-1-piperidinesulfonamides
DE1568626B2 (en) BenzolsuHonylureas, their salts, processes for their production and pharmaceutical preparations containing them
EP0047496A1 (en) Sulfonyl ureas, processes for their production, pharmaceutical compositions based on these compounds and their use
EP0031088A1 (en) Benzene-sulfonyl ureas, processes for their preparation, pharmaceutical compositions based on these compounds and their use
DE2230543A1 (en) BENZENE SULFONYL URUBE AND METHOD FOR MANUFACTURING IT
US3936455A (en) Piperidinesulfonylurea derivatives
DE2027950A1 (en) Benzenesulfonylureas and process for their preparation
EP0029983A1 (en) Benzenesulfonyl ureas, processes for their preparation and pharmaceutical compositions containing these compounds
KR800000451B1 (en) Process for preparing benzenesulfonyl ureas
DE1188589B (en) Process for the preparation of benzenesulfonylureas